United Kingdom1 robot tracked

CMR Surgical

CMR Surgical makes Versius, which is at stage 5 of 5: regulator-cleared or mass market.

Website: cmrsurgical.com
Based in: United Kingdom
Latest milestone: 12 Oct 2026

01Robots

What CMR Surgical makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

VersiusMedical · Modular surgical robotStage 5 of 5 · Regulator-cleared or mass marketVersius is a small, modular surgical robot from the UK. Each arm is a separate unit, so a hospital can use only as many arms as an operation needs and move it between rooms.Used in hospitals in more than 30 countries, the company says. In the US it is cleared only for gallbladder removal, and US sales began in 2026.The full record

02Track record

Every dated event

12 Oct 2026Milestone
Stryker agreed to invest about $400 million in CMR Surgical and become the only sales agent for Versius in the US. Stryker also got an option to buy the whole company later. The deal still needs regulatory approval.
CMR Surgical press release, 12 Oct 2026Company-reported
29 April 2026Milestone
CMR asked the FDA to clear Versius Plus for gynecologic surgery.
CMR Surgical press release, 29 Apr 2026Company-reported
26 March 2026Milestone
CMR launched Versius in the US and said more than 45,000 patients worldwide had been treated with it.
CMR Surgical press release, 26 Mar 2026Company-reported
16 Dec 2025Regulator
The FDA cleared the newer Versius Plus through the 510(k) route, also for gallbladder removal.
CMR Surgical press release, 16 Dec 2025Company-reported
4 April 2025Milestone
CMR Surgical raised more than $200 million from existing investors and new investor Trinity Capital.
CMR Surgical press release, 4 Apr 2025Company-reported
14 Oct 2024Regulator
The FDA granted Versius marketing authorization through the De Novo route, for gallbladder removal in adults 22 and older.
CMR Surgical press release, 14 Oct 2024Company-reported

03Money

How it's funded

Latest funding round we could confirm: Stryker agreed to invest about $400 million in CMR Surgical, with an exclusive option to buy the whole company later. The deal still needs regulatory approvals. CMR Surgical press release, 12 Oct 2026 Company-reported

All robot stocks, funding and suppliers